Plask

Plask is competing at the commodity end of a commoditizing market with the sector's thinnest balance sheet: about $2.56M raised, no disclosed round since October 2021 — nearly five years — and a pricing model that has already migrated to metered credits, the classic signature of inference costs pressing on freemium margins. The low end it owns is precisely the segment going to zero: Rokoko gives Vision away free, DeepMotion and a dozen web tools match single-camera quality, open-source pose estimation keeps improving, and the browser-based convenience that differentiates Plask is replicable by any competitor in a quarter — while above it, Move AI's Gen 2 models and production partnerships absorb the quality-sensitive budgets, and generative text-to-motion threatens to bypass video mocap altogether for the stylized indie content that is Plask's core use case. The signals of strategic drift are visible: a five-year-old pre-Series A company operating a hospital AI CRM side business (Laney) is a team hedging its founding market, not compounding within it, and splitting sub-scale resources across animation tooling and healthcare software is how small companies lose both. Korean strategic investors provide patience but also gravitational pull toward domestic niche outcomes rather than global category leadership, and the global market's attention — reviews, benchmarks, production case studies — has visibly consolidated around better-funded Western and open-source alternatives. Public information on revenue, users, and growth is too thin to evidence a breakout. The probable trajectories are absorption into a Korean platform (Naver, Smilegate) as a feature team, a quiet pivot toward whichever side business monetizes, or indefinite small-scale survival as the animation market's cheap-but-forgettable option.